Companies / BOC Sciences / Lebrikizumab
BOC Sciences

Lebrikizumab | BOC Sciences

Lebrikizumab is a humanized monoclonal antibody that binds to IL-13. Lebrikizumab has the potential for the treatment of atopic dermatitis (AD).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.